These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8238640)

  • 1. Continuation pharmacotherapy of borderline personality disorder with haloperidol and phenelzine.
    Cornelius JR; Soloff PH; Perel JM; Ulrich RF
    Am J Psychiatry; 1993 Dec; 150(12):1843-8. PubMed ID: 8238640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol vs. phenelzine in continuation therapy of borderline disorder.
    Cornelius JR; Soloff PH; George A; Ulrich RF; Perel JM
    Psychopharmacol Bull; 1993; 29(2):333-7. PubMed ID: 8290683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of phenelzine and haloperidol in borderline personality disorder.
    Soloff PH; Cornelius J; George A; Nathan S; Perel JM; Ulrich RF
    Arch Gen Psychiatry; 1993 May; 50(5):377-85. PubMed ID: 8489326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial.
    Jarrett RB; Schaffer M; McIntire D; Witt-Browder A; Kraft D; Risser RC
    Arch Gen Psychiatry; 1999 May; 56(5):431-7. PubMed ID: 10232298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenelzine, imipramine, and placebo in borderline patients meeting criteria for atypical depression.
    Parsons B; Quitkin FM; McGrath PJ; Stewart JW; Tricamo E; Ocepek-Welikson K; Harrison W; Rabkin JG; Wager SG; Nunes E
    Psychopharmacol Bull; 1989; 25(4):524-34. PubMed ID: 2698483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study.
    Nickel MK; Muehlbacher M; Nickel C; Kettler C; Pedrosa Gil F; Bachler E; Buschmann W; Rother N; Fartacek R; Egger C; Anvar J; Rother WK; Loew TH; Kaplan P
    Am J Psychiatry; 2006 May; 163(5):833-8. PubMed ID: 16648324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in pharmacotherapy of borderline disorders. A double-blind study of amitriptyline, haloperidol, and placebo.
    Soloff PH; George A; Nathan RS; Schulz PM; Ulrich RF; Perel JM
    Arch Gen Psychiatry; 1986 Jul; 43(7):691-7. PubMed ID: 3521532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study.
    Linehan MM; McDavid JD; Brown MZ; Sayrs JH; Gallop RJ
    J Clin Psychiatry; 2008 Jun; 69(6):999-1005. PubMed ID: 18466045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
    Hollander E; Allen A; Lopez RP; Bienstock CA; Grossman R; Siever LJ; Merkatz L; Stein DJ
    J Clin Psychiatry; 2001 Mar; 62(3):199-203. PubMed ID: 11305707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open trial of valproate in borderline personality disorder.
    Stein DJ; Simeon D; Frenkel M; Islam MN; Hollander E
    J Clin Psychiatry; 1995 Nov; 56(11):506-10. PubMed ID: 7592502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of personality factors in depression].
    Quitkin FM
    Encephale; 1993 Aug; 19 Spec No 3():491-2. PubMed ID: 8299548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of low and moderate dosages of extended-release quetiapine in borderline personality disorder: a randomized, double-blind, placebo-controlled trial.
    Black DW; Zanarini MC; Romine A; Shaw M; Allen J; Schulz SC
    Am J Psychiatry; 2014 Nov; 171(11):1174-82. PubMed ID: 24968985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of phenelzine in continuation therapy.
    Davidson J; Raft D
    Neuropsychobiology; 1984; 11(3):191-4. PubMed ID: 6433222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder.
    Soler J; Pascual JC; Campins J; Barrachina J; Puigdemont D; Alvarez E; Pérez V
    Am J Psychiatry; 2005 Jun; 162(6):1221-4. PubMed ID: 15930077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder.
    Hollander E; Swann AC; Coccaro EF; Jiang P; Smith TB
    Am J Psychiatry; 2005 Mar; 162(3):621-4. PubMed ID: 15741486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study.
    Frankenburg FR; Zanarini MC
    J Clin Psychiatry; 2002 May; 63(5):442-6. PubMed ID: 12019669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of borderline and schizotypal patients to small doses of thiothixene and haloperidol.
    Serban G; Siegel S
    Am J Psychiatry; 1984 Nov; 141(11):1455-8. PubMed ID: 6388363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression.
    Bauer M; Bschor T; Kunz D; Berghöfer A; Ströhle A; Müller-Oerlinghausen B
    Am J Psychiatry; 2000 Sep; 157(9):1429-35. PubMed ID: 10964859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.